Trimebutine

CAS No. 39133-31-8

Trimebutine( —— )

Catalog No. M14347 CAS No. 39133-31-8

Trimebutine is a drug with antimuscarinic and weak mu opioid agonist effects.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 28 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G 28 In Stock

Biological Information

  • Product Name
    Trimebutine
  • Note
    Research use only, not for human use.
  • Brief Description
    Trimebutine is a drug with antimuscarinic and weak mu opioid agonist effects.
  • Description
    Trimebutine is a drug with antimuscarinic and weak mu opioid agonist effects.Trimebutine is an agonist of peripheral mu, kappa and delta opiate receptors, used as spasmolytic agent for treatment of both acute and chronic abdominal pain.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Endocrinology/Hormones
  • Target
    Opioid Receptor
  • Recptor
    Opioid Receptor
  • Research Area
    Metabolic Disease
  • Indication
    ——

Chemical Information

  • CAS Number
    39133-31-8
  • Formula Weight
    387.47
  • Molecular Formula
    C22H29NO5
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: 50 mg/mL (129.04 mM)
  • SMILES
    CCC(COC(=O)C1=CC(OC)=C(OC)C(OC)=C1)(N(C)C)C1=CC=CC=C1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Prescrire Int. 2013 Oct;22(142):241-2.
molnova catalog
related products
  • (20R)-Protopanaxdiol

    Protopanaxdiol has the effect of anti-tumor through increasing the activity of body immunity, inhibiting tumor interstitial microvascular density and its proliferation activity.

  • (+)-Matrine

    Matrine is an alkaloid found in plants from the Sophora genus. It has a variety of pharmacological effects, including anti-Y effects, and action as a kappa opioid receptor and u-receptor agonist.

  • Alvimopan monohydrat...

    A selective peripherally acting μ-opioid antagonist with IC50 of 1.7 nM for the treatment of postoperative ileus.